Lemnisca a Bio-AI start-up focused on biomanufacturing  has secured pre-seed investment from Theia Ventures, along with support from PointOne Capital and Dr. Satakarni Makkapati. The fresh funds will go towards setting up and expanding its Bengaluru laboratory, building out its core AI platform, and launching early-stage pilots to test adoption in real-world bioprocessing environments.

The core idea behind Lemnisca is to bring predictability and scale to biomanufacturing operations a space that’s typically constrained by unpredictable biological variability when moving from lab to industrial scale. Lemnisca’s “science-aware AI” integrates real-time data from fermentation labs with dry-lab computational models to simulate and optimise microbial processes, allowing operators to anticipate performance, tweak parameters, and avoid surprises. This hybrid “wet-lab + dry-lab” approach aims to make scale-up faster and more reliable.

According to Lemnisca leadership, the platform could reduce the time taken to scale bioprocesses by up to 50% and improve operating efficiency by roughly 25%. The start-up is already inviting pilot collaborations from fermentation-based manufacturers, contract-development and manufacturing organisations (CDMOs), original equipment manufacturers (OEMs), system integrators (SIs), and global ingredient brands signalling ambitions for broad industrial adoption.

Theia Ventures, known for backing deep-tech and decarbonization-oriented start-ups, said the investment reflects its belief that bio-based manufacturing (as opposed to petrochemical-based) needs smart digital tools to scale sustainably. A partner at Theia Ventures commented that Lemnisca’s team brings practical experience and vision making them ideal to build the “digital operating system” for next-gen biomanufacturing.